Literature DB >> 28476736

NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.

Al B Benson1, Michael I D'Angelica2, Daniel E Abbott3, Thomas A Abrams4, Steven R Alberts5, Daniel Anaya Saenz6, Chandrakanth Are7, Daniel B Brown8, Daniel T Chang9, Anne M Covey2, William Hawkins10, Renuka Iyer11, Rojymon Jacob12, Andrea Karachristos13, R Kate Kelley14, Robin Kim15, Manisha Palta16, James O Park17, Vaibhav Sahai18, Tracey Schefter19, Carl Schmidt20, Jason K Sicklick21, Gagandeep Singh22, Davendra Sohal23, Stacey Stein24, G Gary Tian25, Jean-Nicolas Vauthey26, Alan P Venook14, Andrew X Zhu27, Karin G Hoffmann28, Susan Darlow28.   

Abstract

The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.
Copyright © 2017 by the National Comprehensive Cancer Network.

Entities:  

Mesh：

Year:  2017        PMID： 28476736      PMCID： PMC5557008          DOI： 10.6004/jnccn.2017.0059

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


  111 in total

1.  Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

Authors:  Bruno Sangro; Livio Carpanese; Roberto Cianni; Rita Golfieri; Daniele Gasparini; Samer Ezziddin; Philipp M Paprottka; Francesco Fiore; Mark Van Buskirk; Jose Ignacio Bilbao; Giuseppe Maria Ettorre; Rita Salvatori; Emanuela Giampalma; Onelio Geatti; Kai Wilhelm; Ralf Thorsten Hoffmann; Francesco Izzo; Mercedes Iñarrairaegui; Carlo Ludovico Maini; Carlo Urigo; Alberta Cappelli; Alessandro Vit; Hojjat Ahmadzadehfar; Tobias Franz Jakobs; Secondo Lastoria
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

2.  A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.

Authors:  L Lladó; J Virgili; J Figueras; C Valls; J Dominguez; A Rafecas; J Torras; J Fabregat; J Guardiola; E Jaurrieta
Journal:  Cancer       Date:  2000-01-01       Impact factor: 6.860

3.  Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.

Authors:  Wen-Yen Huang; Yee-Min Jen; Meei-Shyuan Lee; Li-Ping Chang; Chang-Ming Chen; Kai-Hsiung Ko; Kuen-Tze Lin; Jang-Chun Lin; Hsing-Lung Chao; Chun-Shu Lin; Yu-Fu Su; Chao-Yueh Fan; Yao-Wen Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-17       Impact factor: 7.038

4.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

5.  Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

Authors:  Shi-Ming Lin; Chun-Jung Lin; Chen-Chun Lin; Chao-Wei Hsu; Yi-Cheng Chen
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

6.  Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up.

Authors:  Guido Bonomo; Vittorio Pedicini; Lorenzo Monfardini; Paolo Della Vigna; Dario Poretti; Gianluigi Orgera; Franco Orsi
Journal:  Cardiovasc Intervent Radiol       Date:  2009-12-03       Impact factor: 2.740

Review 7.  Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review.

Authors:  Saad-M Ibrahim; Robert-J Lewandowski; Kent-T Sato; Vanessa-L Gates; Laura Kulik; Mary-F Mulcahy; Robert-K Ryu; Reed-A Omary; Riad Salem
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

8.  Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.

Authors:  Laura M Kulik; Brian I Carr; Mary F Mulcahy; Robert J Lewandowski; Bassel Atassi; Robert K Ryu; Kent T Sato; Al Benson; Albert A Nemcek; Vanessa L Gates; Michael Abecassis; Reed A Omary; Riad Salem
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

9.  Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma.

Authors:  Jianmin Ding; Xiang Jing; Jibin Liu; Yandong Wang; Fengmei Wang; Yijun Wang; Zhi Du
Journal:  Eur J Radiol       Date:  2013-05-28       Impact factor: 3.528

Review 10.  Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies.

Authors:  Yun Ku Cho; Jae Kyun Kim; Mi Young Kim; Hyunchul Rhim; Joon Koo Han
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425
View more
  110 in total

Review 1.  Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma.

Authors:  Di-Yang Xie; Zheng-Gang Ren; Jian Zhou; Jia Fan; Qiang Gao
Journal:  Hepatobiliary Surg Nutr       Date:  2017-12       Impact factor: 7.293

Review 2.  Local Arterial Therapies in the Management of Unresectable Hepatocellular Carcinoma.

Authors:  Samdeep K Mouli; Laura W Goff
Journal:  Curr Treat Options Oncol       Date:  2017-10-27

Review 3.  LI-RADS 2017: An update.

Authors:  Ania Z Kielar; Victoria Chernyak; Mustafa R Bashir; Richard K Do; Kathryn J Fowler; Donald G Mitchell; Milena Cerny; Khaled M Elsayes; Cynthia Santillan; Aya Kamaya; Yuko Kono; Claude B Sirlin; An Tang
Journal:  J Magn Reson Imaging       Date:  2018-04-06       Impact factor: 4.813

4.  Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality.

Authors:  Nadim Mahmud; Binu John; Tamar H Taddei; David S Goldberg
Journal:  Clin Transplant       Date:  2019-06-25       Impact factor: 2.863

5.  Validation of the prognostic performance in various nodal staging systems for gallbladder cancer: results of a multicenter study.

Authors:  Woohyung Lee; Chi-Young Jeong; Young Hoon Kim; Young Hoon Roh; Myung Hee Yoon; Hyung Il Seo; Jeong-Ik Park; Bo-Hyun Jung; Dong Hoon Shin; Young Il Choi; Je Ho Ryu; Kwang Ho Yang; Chang Soo Choi; Yo-Han Park; Yang Won Nah; Soon-Chan Hong
Journal:  Langenbecks Arch Surg       Date:  2019-08-14       Impact factor: 3.445

Review 6.  Developing a Roadmap for Interventional Oncology.

Authors:  Stefan O Schoenberg; Ulrike I Attenberger; Stephen B Solomon; Ralph Weissleder
Journal:  Oncologist       Date:  2018-06-29

7.  Transcriptomics Associates Molecular Features with 18F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma.

Authors:  Sandi A Kwee; Maarit Tiirikainen; Miles M Sato; Jared D Acoba; Runmin Wei; Wei Jia; Loic Le Marchand; Linda L Wong
Journal:  Cancer Res       Date:  2019-02-13       Impact factor: 12.701

8.  Management of ruptured liver segment IV hepatocellular carcinoma: is transarterial embolization (TAE) superior to chemoembolization (TACE)?-the jury is still out.

Authors:  Anargyros Bakopoulos; Nikolaos Koliakos; Diamantis I Tsilimigras; Dimitrios Schizas; Demetrios Moris; Argiris Angelopoulos; Spyridon Spanakos; Eleftherios Spartalis; Pavlos Patapis; Panagiotis Skandalakis; Theodoros Troupis
Journal:  Ann Transl Med       Date:  2018-07

9.  Concordance Study in Hepatectomy Recommendations Between Watson for Oncology and Clinical Practice for Patients with Hepatocellular Carcinoma in China.

Authors:  Weiqi Zhang; Shuo Qi; Jiaming Zhuo; Sai Wen; Chihua Fang
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

10.  Evaluation of the Heat Sink Effect After Transarterial Embolization When Performed in Combination with Thermal Ablation of the Liver in a Rabbit Model.

Authors:  Charles J Puza; Qi Wang; Charles Y Kim
Journal:  Cardiovasc Intervent Radiol       Date:  2018-07-23       Impact factor: 2.740
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.